Synopsis
Synopsis
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Decadron Phosphate
2. Dexamethasone 21-phosphate
3. Dexamethasone 21-phosphate, (6alpha,11beta,16alpha)-isomer
4. Dexamethasone 21-phosphate, Copper (+2) Salt (2:3), (11beta,16alpha)-isomer
5. Dexamethasone 21-phosphate, Disodium Salt, (11beta,16alpha)-isomer
6. Dexamethasone 21-phosphate, Disodium Salt, (6alpha,11beta,16alpha)-isomer
7. Dexamethasone 21-phosphate, Monosodium Salt, (11beta,16alpha)-isomer
8. Dexamethasone 21-phosphate, Sodium Salt, (11beta,16alpha)-isomer
9. Dexamethasone Phosphate
10. Dexamethasone Phosphate Disodium Salt
11. Dexamethasonedisodium Phosphate
12. Solu- Decadron
13. Spersadex
14. Spersadox
1. 2392-39-4
2. Dexamethasone 21-phosphate Disodium Salt
3. Dalalone
4. Dexadreson
5. Dexamethasone Disodium Phosphate
6. Megacort
7. Soldesam
8. Dexagro
9. 55203-24-2
10. Decadron Phosphate
11. Dexabene
12. Orgadrone
13. Ak-dex
14. Sodium Dexamethasone Phosphate
15. Dexamethasone 21-(disodium Phosphate)
16. Dexamethasone Phosphate Disodium
17. 2392-39-4 (disodium)
18. Chebi:4462
19. Tlc399
20. Tlc-399
21. Ai9376y64p
22. Nsc-756722
23. Disodium;[2-[(8s,9r,10s,11s,13s,14s,16r,17r)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] Phosphate
24. Spersadox
25. Decdan
26. Solu-decadron
27. Maxidex Ointment
28. Dsstox_cid_27429
29. Dsstox_rid_82342
30. Dsstox_gsid_47429
31. Hexadrol Injectable
32. Disodium [2-[(8s,9r,10s,11s,13s,14s,16r,17r)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] Phosphate
33. Colvasone
34. Dexagel
35. Onadron
36. Baldex
37. Mfcd00079105
38. Dexaject Sp
39. Egp 437
40. Sodium 2-((8s,9r,10s,11s,13s,14s,16r,17r)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3h-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl Phosphate
41. Cas-2392-39-4
42. Disodium Dexamethasone Phosphate
43. 21-disodium Phosphate Dexamethasone
44. Einecs 219-243-0
45. Dexamethasone-21-phosphate Disodium Salt
46. Dexamethazone Sodium Phosphate
47. Unii-ai9376y64p
48. Ncgc00094644-01
49. Dalalone (tn)
50. Mephamesone
51. Soludecadron
52. Totocortin
53. Solupen N
54. Egp437. Dex-phos
55. Dexamethasone Sodium Phosphate [usp:ban:jan]
56. Schembl7778
57. Decadron Inhalation, Injection, Ophthalmic Solution And Ointment, And Topical Cream
58. 9-fluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 21-(dihydrogen Phosphate) Disodium Salt
59. Chembl2021430
60. Dtxsid3047429
61. Dexamethasone Phosphate Sodium Salt
62. Bcp16805
63. Tox21_113181
64. Tox21_302586
65. S4028
66. Akos015896357
67. Akos015951212
68. Am84812
69. Ccg-269820
70. Ks-1150
71. Nsc 756722
72. Ncgc00256783-01
73. Ac-17992
74. Dexamethasone Sodium Phosphate (jan/usp)
75. Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, Disodium Salt, (11.beta.,16.alpha.)-
76. Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, Disodium Salt, (11beta,16alpha)-
77. Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-alpha-methyl-, 21-(dihydrogen Phosphate) Disodium Salt
78. Dexamethasone Phosphate (as Sodium)
79. Dexamethasone Sodium Phosphate [jan]
80. B1588
81. Dexamethasone Sodium Phosphate [mart.]
82. Dexamethasone Sodium Phosphate [vandf]
83. En300-52795
84. C08175
85. D00975
86. Dexamethasone Sodium Phosphate [usp-rs]
87. Dexamethasone Sodium Phosphate [who-dd]
88. Dexamethasone Sodium Phosphate [who-ip]
89. A816989
90. A830522
91. Dexamethasone 21-phosphate Disodium Salt, >=98%
92. Dexamethasone Sodium Phosphate [green Book]
93. Dexamethasone Sodium Phosphate [orange Book]
94. Dexamethasone Sodium Phosphate [usp Impurity]
95. Dexamethasoni Natrii Phosphas [who-ip Latin]
96. Dexamethasone 21-phosphate Disodium Salt [mi]
97. Dexamethasone Sodium Phosphate [usp Monograph]
98. Q27106391
99. Neodecadron Component Dexamethasone Sodium Phosphate
100. Dexamethasone Sodium Phosphate Component Of Neodecadron
101. Dexamethasone Sodium Phosphate, British Pharmacopoeia (bp) Reference Standard
102. Dexamethasone Sodium Phosphate, European Pharmacopoeia (ep) Reference Standard
103. Dexamethasone Sodium Phosphate, United States Pharmacopeia (usp) Reference Standard
104. 9-fluoro-11.beta.,17,21-trihydroxy-16.alpha.-methylpregna-1,4-diene-3,20-dione 21-(dihydrogen Phosphate) Disodium Salt
105. Dexamethasone Sodium Phosphate For Peak Identification, European Pharmacopoeia (ep) Reference Standard
106. Dexamethasone Sodium Phosphate, Pharmaceutical Secondary Standard; Certified Reference Material
107. Disodium [2-[(8s,9r,10s,11s,13s,14s,16r,17r)-9-fluoranyl-10,13,16-trimethyl-11,17-bis(oxidanyl)-3-oxidanylidene-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxidanylidene-ethyl] Phosphate
108. Disodium 9-fluoro-11beta,17-dihydroxy-16alpha-methyl-3,20-dioxopregna-1,4-dien-21-yl Phosphate
109. Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, Sodium Salt (1:2), (11beta,16alpha)-
| Molecular Weight | 516.4 g/mol |
|---|---|
| Molecular Formula | C22H28FNa2O8P |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 3 |
| Exact Mass | 516.13012157 g/mol |
| Monoisotopic Mass | 516.13012157 g/mol |
| Topological Polar Surface Area | 147 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 962 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
| 1 of 2 | |
|---|---|
| Drug Name | Dexamethasone sodium phosphate |
| Drug Label | Dexamethasone sodium phosphate is a water-soluble inorganic ester of dexamethasone. It occurs as a white or slightly yellow crystalline powder, is odorless or has a slight odor of alcohol, is exceedingly hygroscopic and is freely soluble in water.... |
| Active Ingredient | Dexamethasone sodium phosphate |
| Dosage Form | Injectable; Solution/drops |
| Route | Ophthalmic, otic; Injection |
| Strength | eq 10mg phosphate/ml; eq 0.1% phosphate; eq 4mg phosphate/ml |
| Market Status | Prescription |
| Company | Fresenius Kabi Usa; Hikma Maple; Bausch And Lomb; Alcon Pharms; Luitpold; Agila Speclts |
| 2 of 2 | |
|---|---|
| Drug Name | Dexamethasone sodium phosphate |
| Drug Label | Dexamethasone sodium phosphate is a water-soluble inorganic ester of dexamethasone. It occurs as a white or slightly yellow crystalline powder, is odorless or has a slight odor of alcohol, is exceedingly hygroscopic and is freely soluble in water.... |
| Active Ingredient | Dexamethasone sodium phosphate |
| Dosage Form | Injectable; Solution/drops |
| Route | Ophthalmic, otic; Injection |
| Strength | eq 10mg phosphate/ml; eq 0.1% phosphate; eq 4mg phosphate/ml |
| Market Status | Prescription |
| Company | Fresenius Kabi Usa; Hikma Maple; Bausch And Lomb; Alcon Pharms; Luitpold; Agila Speclts |
Glucocorticoids
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - INJECTABLE;INJECTION - EQ 4MG PHOSPH...DOSAGE - INJECTABLE;INJECTION - EQ 4MG PHOSPHATE/ML
USFDA APPLICATION NUMBER - 84916
DOSAGE - INJECTABLE;INJECTION - EQ 4MG PHOSPH...DOSAGE - INJECTABLE;INJECTION - EQ 4MG PHOSPHATE/ML
USFDA APPLICATION NUMBER - 87440
Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Solubilizers
Parenteral
Topical
Controlled & Modified Release
Emulsifying Agents
Thickeners and Stabilizers
Film Formers & Plasticizers
Surfactant & Foaming Agents
Co-Processed Excipients
Direct Compression
Rheology Modifiers
API Stability Enhancers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
98
PharmaCompass offers a list of Dexamethasone Sodium Phosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dexamethasone Sodium Phosphate manufacturer or Dexamethasone Sodium Phosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dexamethasone Sodium Phosphate manufacturer or Dexamethasone Sodium Phosphate supplier.
PharmaCompass also assists you with knowing the Dexamethasone Sodium Phosphate API Price utilized in the formulation of products. Dexamethasone Sodium Phosphate API Price is not always fixed or binding as the Dexamethasone Sodium Phosphate Price is obtained through a variety of data sources. The Dexamethasone Sodium Phosphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dexamethasone Sodium Phosphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dexamethasone Sodium Phosphate, including repackagers and relabelers. The FDA regulates Dexamethasone Sodium Phosphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dexamethasone Sodium Phosphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dexamethasone Sodium Phosphate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dexamethasone Sodium Phosphate supplier is an individual or a company that provides Dexamethasone Sodium Phosphate active pharmaceutical ingredient (API) or Dexamethasone Sodium Phosphate finished formulations upon request. The Dexamethasone Sodium Phosphate suppliers may include Dexamethasone Sodium Phosphate API manufacturers, exporters, distributors and traders.
click here to find a list of Dexamethasone Sodium Phosphate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dexamethasone Sodium Phosphate DMF (Drug Master File) is a document detailing the whole manufacturing process of Dexamethasone Sodium Phosphate active pharmaceutical ingredient (API) in detail. Different forms of Dexamethasone Sodium Phosphate DMFs exist exist since differing nations have different regulations, such as Dexamethasone Sodium Phosphate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dexamethasone Sodium Phosphate DMF submitted to regulatory agencies in the US is known as a USDMF. Dexamethasone Sodium Phosphate USDMF includes data on Dexamethasone Sodium Phosphate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dexamethasone Sodium Phosphate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dexamethasone Sodium Phosphate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Dexamethasone Sodium Phosphate Drug Master File in Japan (Dexamethasone Sodium Phosphate JDMF) empowers Dexamethasone Sodium Phosphate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Dexamethasone Sodium Phosphate JDMF during the approval evaluation for pharmaceutical products. At the time of Dexamethasone Sodium Phosphate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Dexamethasone Sodium Phosphate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Dexamethasone Sodium Phosphate Drug Master File in Korea (Dexamethasone Sodium Phosphate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Dexamethasone Sodium Phosphate. The MFDS reviews the Dexamethasone Sodium Phosphate KDMF as part of the drug registration process and uses the information provided in the Dexamethasone Sodium Phosphate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Dexamethasone Sodium Phosphate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Dexamethasone Sodium Phosphate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Dexamethasone Sodium Phosphate suppliers with KDMF on PharmaCompass.
A Dexamethasone Sodium Phosphate CEP of the European Pharmacopoeia monograph is often referred to as a Dexamethasone Sodium Phosphate Certificate of Suitability (COS). The purpose of a Dexamethasone Sodium Phosphate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Dexamethasone Sodium Phosphate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Dexamethasone Sodium Phosphate to their clients by showing that a Dexamethasone Sodium Phosphate CEP has been issued for it. The manufacturer submits a Dexamethasone Sodium Phosphate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Dexamethasone Sodium Phosphate CEP holder for the record. Additionally, the data presented in the Dexamethasone Sodium Phosphate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Dexamethasone Sodium Phosphate DMF.
A Dexamethasone Sodium Phosphate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Dexamethasone Sodium Phosphate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Dexamethasone Sodium Phosphate suppliers with CEP (COS) on PharmaCompass.
A Dexamethasone Sodium Phosphate written confirmation (Dexamethasone Sodium Phosphate WC) is an official document issued by a regulatory agency to a Dexamethasone Sodium Phosphate manufacturer, verifying that the manufacturing facility of a Dexamethasone Sodium Phosphate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Dexamethasone Sodium Phosphate APIs or Dexamethasone Sodium Phosphate finished pharmaceutical products to another nation, regulatory agencies frequently require a Dexamethasone Sodium Phosphate WC (written confirmation) as part of the regulatory process.
click here to find a list of Dexamethasone Sodium Phosphate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dexamethasone Sodium Phosphate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dexamethasone Sodium Phosphate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dexamethasone Sodium Phosphate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dexamethasone Sodium Phosphate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dexamethasone Sodium Phosphate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dexamethasone Sodium Phosphate suppliers with NDC on PharmaCompass.
Dexamethasone Sodium Phosphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dexamethasone Sodium Phosphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dexamethasone Sodium Phosphate GMP manufacturer or Dexamethasone Sodium Phosphate GMP API supplier for your needs.
A Dexamethasone Sodium Phosphate CoA (Certificate of Analysis) is a formal document that attests to Dexamethasone Sodium Phosphate's compliance with Dexamethasone Sodium Phosphate specifications and serves as a tool for batch-level quality control.
Dexamethasone Sodium Phosphate CoA mostly includes findings from lab analyses of a specific batch. For each Dexamethasone Sodium Phosphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dexamethasone Sodium Phosphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Dexamethasone Sodium Phosphate EP), Dexamethasone Sodium Phosphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dexamethasone Sodium Phosphate USP).
